AstraZeneca is one of the world’s largest biopharmaceutical companies. Our aim is to develop and market innovative and cost effective drugs that promote healt and quality of life.
Oncology is one of our priority areas. Future cancer treatment is moving towards a targeted treatment of the underlying mechanisms of the disease. AstraZeneca is working to develop targeted medicines for a variety of cancer diagnoses by using various mechanisms. AstraZeneca’s objective is to identify the most effective combinations of specific molecules within immunomodulating cancer treatment. Due to the biological complexity of most types of cancer, combination therapy has proven to be the most effective treatment against cancer